Palipase MT-16 16,000 UNT / 48,000 UNT / 48,000 UNT Delayed Release Oral Capsule
RxNorm 809258
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 809258 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Palipase MT-16 16,000 UNT / 48,000 UNT / 48,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 48000 UNT / lipase 16000 UNT / protease 48000 UNT Delayed Release Oral Capsule [Palipase]
(Atom ID: 12361207)
SY
Synonym (SY):
Palipase (amylases 48,000 UNT / endopeptidases 48,000 UNT / lipase 16,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845931)
SY
Synonym (SY):
Palipase MT 16 (amylase 48,000 UNT / lipase 16,000 UNT / protease 48,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845930)
SY
Synonym (SY):
Palipase MT 16 Delayed Release Oral Capsule
(Atom ID: 6339252)
PSN